Patents
Patents
As of June 2018, our company has applied for 16 patents, including 5 invention patents related to tumor-targeting chimeric antigen receptors and 11 utility model patents. There are 2 product service trademarks under application. . .
Patents
As of June 2018, our company has applied for 16 patents, including 5 invention patents related to tumor-targeting chimeric antigen receptors and 11 utility model patents. There are 2 product service trademarks under application. . .